Table 4 Status of E-Cadherin and COX-2 hypermethylation in healthy, periodontitis patients and breast cancer patients.
From: Epigenetic change in e-cardherin and COX-2 to predict chronic periodontitis
Groups | Hypermethylation of Cox-2(%) | Chi-square Pearson | Relative Risk (95% confidence Intervals) | Hypermethylation of E-cadherin(%) | Chi-square Pearson | Relative Risk (95% confidence Intervals) |
|---|---|---|---|---|---|---|
Healthy subjects | 0/108(0%) | --- | --- | 0/108(0%) | ---- | --- |
(N = 108) | Â | Â | Â | Â | Â | Â |
Periodontitis patients | 21/110(19%) | 19.82 | 0.0485 | 28/110(25%) | 28.43 | 0.1091 |
(N = 110) | Â | p < 0.0001 | 0.0066-0.3543 | Â | p < 0.0001 | 0.005-0.2627 |
Breast cancer patients | 37/106(35%) | 42.29 | 0.0265 | 40/106(38%) | 46.8 | 0.0245 |
(N = 106) | Â | p < 0.0001 | 0.0037-0.1899 | Â | p < 0.0001 | 0.0034-0.1753 |